Профиль компании
- Фондовый код
- SMMT
- ISIN-код
- US86627T1088
- Валюта
- US Dollar (USD)
- Дата IPO
- 2015-03-05

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small l...